Kieran McCafferty, MB BChir, MRCP, MDres - The Latest News on SGLT2 Inhibitors in Chronic Kidney Disease: Improving Outcomes With Early Intervention

Please visit answersincme.com/CKS860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in nephrology discusses when to use SGLT2 inhibitors in patients with chronic kidney disease. Upon completion of this activity, participants should be better able to: Describe the benefits of SGLT2 inhibitor use in the management of CKD; Define strategies for the early implementation of SGLT2 inhibitor therapy in CKD; and Identify appropriate patient populations for the early implementation of SGLT2 inhibitor therapy in CKD.